Key facts
- EnVision Endoscopy’s last known valuation is $45.0M (Mar 2026).
- It has raised $12.5M; the latest was Later Stage VC ($7.0M) in Mar 2026.
- Notable investors include US National Science Foundation, MassChallenge, MedTech Innovator, MassVentures, MassMEDIC — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for EnVision Endoscopy
- ·The full record, as it builds
Funding rounds
No funding rounds for EnVision Endoscopy are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About EnVision Endoscopy
Developer of a medical device designed for use in endoscopic surgeries. The company's device is compatible with standard endoscopes for tissue approximation for surgeries with an image-guided suturing system, enabling hospitals to reduce the procedure time and mortality rates.
- Sector
- Healthcare
- HQ
- Lowell, MA, United States
- Founded
- 2018
- Employees
- 5
- Website
- envisionendoscopy.com/
- Ownership
- Privately Held (backing)
EnVision Endoscopy doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in EnVision Endoscopy shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on EnVision Endoscopy in its N-PORT filings yet. We sweep new filings monthly.